Traditional Chinese Medicine Systems Pharmacology Platform(TCMSP)
Since its launch in 2013, TCMSP 1.0 has served over a million traditional Chinese medicine researchers
worldwide, becoming the de facto standard database cited in virtually each network(system) pharmacology paper
(Ru et al., J Cheminformatics, 2014). A decade of honing, and the sword is finally drawn. The original team has
completely rebuilt TCMSP into a next-generation of AI research platform — now covering approximately 2,400,000
compounds, 600,787 natural medicinal resources — including 478,652 plants, 46,318 animals, 31,247 marine
organisms, 24,583 microorganisms, 17,892 bacteria, and 2,095 minerals — 29,490 disease entities, 66,800 targets,
approximately 140 million disease-target relationships, and 2 billion molecule-target interactions — with
analytical capabilities grown from zero to over a hundred tools. Our dedication to the systems pharmacology of
traditional Chinese medicine, however, has never changed.
Q1: Will the legacy platform (tcmsp-e.com) remain available?
A1: Yes. It will remain freely accessible for the long term, and citations in published papers are
unaffected. The new platform is an “extension”, not a “replacement”.
Q2: Can the methodology of the new platform be cited directly?
A2: Yes. Every module provides copy-ready bilingual (Chinese/English) paragraphs with software
versions (AutoDock Vina, clusterProfiler, STRING v12.0, etc.) and parameter thresholds (OB ≥ 15%, DL ≥
0.11, exhaustiveness = 16, etc.), ready to be pasted directly into the Methods section.
Q3: What is the difference between the desktop and web versions?
A3: Web version: powered by cloud computing — start anytime, anywhere, right in your browser. Desktop
version: local inference keeps your data on your own machine, making it the first choice for sensitive
projects; cloud session sync is also supported.